Correlation Between Nuvectis Pharma and Arcellx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Arcellx, you can compare the effects of market volatilities on Nuvectis Pharma and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Arcellx.

Diversification Opportunities for Nuvectis Pharma and Arcellx

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Nuvectis and Arcellx is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Arcellx go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and Arcellx

Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 10.08 times less return on investment than Arcellx. In addition to that, Nuvectis Pharma is 2.54 times more volatile than Arcellx. It trades about 0.0 of its total potential returns per unit of risk. Arcellx is currently generating about 0.12 per unit of volatility. If you would invest  7,125  in Arcellx on September 6, 2024 and sell it today you would earn a total of  1,740  from holding Arcellx or generate 24.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.44%
ValuesDaily Returns

Nuvectis Pharma  vs.  Arcellx

 Performance 
       Timeline  
Nuvectis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Arcellx 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Arcellx are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Arcellx showed solid returns over the last few months and may actually be approaching a breakup point.

Nuvectis Pharma and Arcellx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvectis Pharma and Arcellx

The main advantage of trading using opposite Nuvectis Pharma and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.
The idea behind Nuvectis Pharma and Arcellx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
CEOs Directory
Screen CEOs from public companies around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios